, Volume 5, Issue 2, pp 63-67

Vaccination against hepatitis a and b in patients with hiv

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Patients coinfected with HIV and viral hepatitis A or B are at increased risk for liver-related morbidity and mortality. Although vaccination is safe and effective in the general population, hepatitis A virus and hepatitis B virus transmission may continue in high-risk populations because vaccine response rates lag behind those seen in healthy populations. Poor immune response to vaccine, atypical markers of prior exposure, and difficulty reaching those at risk underlie the challenges facing clinicians and their HIV-infected patients.